ABUS Arbutus Biopharma Corporation logo

ABUS Arbutus Biopharma Corporation

Healthcare
$4.35-2.03%ClosedMarket Cap: $859.3M

As of 2026-05-25

Institutional Ownership Summary

Investors Holding

190

13F Shares

122,025,054

Ownership %

63.6%

New Positions

23

Increased Positions

79

Closed Positions

18

Reduced Positions

43

ETF Exposure
ETF SymbolETF NameShares HeldWeight %
MSGRDirexion mRNA ETF31,6933.00%
GERMETFMG Treatments, Testing and Advancements ETF41,5391.62%
BBCVirtus Biotech Clinical Trials ETF57,8950.76%
SILXETFMG Prime 2x Daily Junior Silver Miners ETF53,1550.67%
VALT46,9030.65%
QQQSInvesco NASDAQ Future Gen 200 ETF15,2150.52%
XBI2,268,0650.14%
IJE381,3660.14%
IWCiShares Micro-Cap ETF381,3660.14%
KOMPState Street SPDR S&P Kensho New Economies Composite ETF629,3910.12%
SMMViShares MSCI USA Small-Cap Min Vol Factor ETF67,8190.11%
LABUDirexion Daily S&P Biotech Bull 3X ETF115,5900.10%
IBBQInvesco Nasdaq Biotechnology ETF11,3100.07%
ESMLiShares ESG Aware MSCI USA Small-Cap ETF273,4780.06%
IBBiShares Biotechnology ETF1,119,4370.06%
VTWG130,8880.04%
IWOiShares Russell 2000 Growth ETF1,172,5600.04%
NLO1,172,5600.04%
GSSCGoldman Sachs ActiveBeta U.S. Small Cap Equity ETF63,7980.03%
PRFZInvesco RAFI US 1500 Small-Mid ETF135,6520.02%